Patents by Inventor Lidia Brownell

Lidia Brownell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230320956
    Abstract: Diarylalkane compounds for use in anti-aging, wrinkle reduction, and extracellular matrix-boosting topical skincare are disclosed. Data and information from clinical trials that demonstrated reduced numbers of fine lines and wrinkles, reduced wrinkle depth, and reduced skin roughness upon treatment with the compound are also disclosed.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Applicant: Unigen, Inc.
    Inventors: Teresa Horm, Lidia Brownell, Qi Jia
  • Publication number: 20220031654
    Abstract: Bioflavonoid compositions for establishment and regulation of homeostasis of host defense mechanism, are disclosed and comprise at least one standardized bioflavonoid extract enriched for at least one free-B-ring flavonoid and at least one standardized bioflavonoid extract enriched for at least one flavan. Contemplated compositions are effective for respiratory diseases and conditions.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Applicant: Unigen, Inc.
    Inventors: Mesfin Yimam, Teresa Horm, Qi Jia, Lidia Brownell, Alexandria O'Neal
  • Publication number: 20220016196
    Abstract: Compositions used and methods are disclosed for regulation of immunity homeostasis including a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or more polysaccharides; and a Rosemary extract enriched for one or more polyphenolic compounds. Compositions for maintenance of immunity homeostasis by regulating HMGB1, comprising a combination of one or more polysaccharides and one or more polyphenolic compounds are disclosed. Methods for treating, managing, promoting regulation of immunity homeostasis in a mammal are disclosed that include administering an effective amount of a composition from 0.01 mg/kg to 500 mg/kg body weight of the mammal.
    Type: Application
    Filed: July 8, 2021
    Publication date: January 20, 2022
    Applicant: Unigen, Inc.
    Inventors: Mesfin Yimam, Ping Jiao, Teresa Horm, Lidia Brownell, Mei Hong, Alexandria O'Neal, Qi Jia